Your activity: 2 p.v.

Selection of blood products for infants with hemolytic disease of the fetus and newborn (HDFN)

Selection of blood products for infants with hemolytic disease of the fetus and newborn (HDFN)
Alloantibody causing HDFN Key characteristics for RBCs:
Rh(D)

Rh(D) negative

Group O* or ABO compatible

Cross-match compatible
ABO incompatibility

Group O*

Rh(D) negative or Rh(D) compatible

Cross-match compatible
Other blood group incompatibility (eg, anti-K, anti-E)

Negative for the offending antigen

Group O* or ABO compatible

Rh(D) negative or Rh(D) compatible

Cross-match compatible
For an exchange transfusion, the RBCs described above are reconstituted with AB plasma (this plasma contains no anti-A or anti-B), or with ABO-compatible plasma.
Rh(D): Rhesus D; RBCs: red blood cells.
* At some institutions, group O RBCs are washed to remove any traces of anti-A or anti-B antibodies. This is most often used for preterm babies because trace amounts of antibodies represent a higher proportion of their blood volume.
¶ At some institutions, group O RBCs are used for all newborns and infants younger than 4 months old, rather than ABO-compatible RBCs. This simplifies and standardizes the blood bank protocol. If nongroup O RBCs are used, the newborn must also be tested for "passive" anti-A and anti-B (ie, anti-A or anti-B of maternal origin). These antibodies are detected by an indirect antiglobulin (Coombs) test, which can be done on the infant's plasma, serum, or eluate of baby's RBC, tested against A and B cells if a direct antiglobulin (Coombs) test is positive for immunoglobulin G. Cord blood can also be used for this purpose.
Courtesy of Jun Teruya, MD, DSc, FCAP
Graphic 97838 Version 4.0